Yu X, Deng Q, Gao X, He L, Hu D, Yang L
Front Endocrinol (Lausanne). 2025; 16:1523785.
PMID: 40034225
PMC: 11872706.
DOI: 10.3389/fendo.2025.1523785.
Mondal J, Zhang J, Qing F, Li S, Kumar D, Huse J
Nat Commun. 2025; 16(1):1378.
PMID: 39910049
PMC: 11799300.
DOI: 10.1038/s41467-025-56347-2.
Kabak E, Foo S, Rafaeva M, Martin I, Bentires-Alj M
Adv Exp Med Biol. 2025; 1464():373-395.
PMID: 39821034
DOI: 10.1007/978-3-031-70875-6_18.
Schreier S, Budchart P, Borwornpinyo S, Adireklarpwong L, Chirappapha P, Triampo W
Breast Cancer (Auckl). 2025; 19():11782234241310596.
PMID: 39803593
PMC: 11724413.
DOI: 10.1177/11782234241310596.
Izadi N, Solar P, Hasanova K, Zamani A, Akbar M, Mrazova K
Fluids Barriers CNS. 2025; 22(1):3.
PMID: 39780275
PMC: 11708195.
DOI: 10.1186/s12987-025-00618-z.
Implication of the Extracellular Matrix in Metastatic Tumor Cell Dormancy.
Redoute-Timonnier C, Auguste P
Cancers (Basel). 2024; 16(23).
PMID: 39682261
PMC: 11639913.
DOI: 10.3390/cancers16234076.
Cell-cell interactions mediating primary and metastatic breast cancer dormancy.
Lenart N, Rao S
Cancer Metastasis Rev. 2024; 44(1):6.
PMID: 39585533
DOI: 10.1007/s10555-024-10223-5.
DNA damage-induced EMT controlled by the PARP-dependent chromatin remodeler ALC1 promotes DNA repair efficiency through RAD51 in tumor cells.
Rajabi F, Smith R, Liu-Bordes W, Schertzer M, Huet S, Londono-Vallejo A
Mol Biol Cell. 2024; 35(12):ar151.
PMID: 39504452
PMC: 11656468.
DOI: 10.1091/mbc.E24-08-0370.
Detection, significance and potential utility of circulating tumor cells in clinical practice in breast cancer (Review).
Rusnakova D, Aziri R, Dubovan P, Jurik M, Mego M, Pindak D
Oncol Lett. 2024; 29(1):10.
PMID: 39492933
PMC: 11526295.
DOI: 10.3892/ol.2024.14756.
Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis.
Dalla E, Papanicolaou M, Park M, Barth N, Hou R, Segura-Villalobos D
Cell. 2024; 187(23):6631-6648.e20.
PMID: 39378878
PMC: 11568918.
DOI: 10.1016/j.cell.2024.09.016.
An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche.
Baldassarri I, Tavakol D, Graney P, Chramiec A, Hibshoosh H, Vunjak-Novakovic G
Proc Natl Acad Sci U S A. 2024; 121(42):e2405257121.
PMID: 39374382
PMC: 11494322.
DOI: 10.1073/pnas.2405257121.
Navigating precision: the crucial role of next-generation sequencing recurrence risk assessment in tailoring adjuvant therapy for hormone receptor-positive, human epidermal growth factor Receptor2-negative early breast cancer.
Xu Y, Qi Y, Lu Z, Tan Y, Chen D, Luo H
Cancer Biol Ther. 2024; 25(1):2405060.
PMID: 39304993
PMC: 11418226.
DOI: 10.1080/15384047.2024.2405060.
Circulating tumor cells: from new biological insights to clinical practice.
Gu X, Wei S, Lv X
Signal Transduct Target Ther. 2024; 9(1):226.
PMID: 39218931
PMC: 11366768.
DOI: 10.1038/s41392-024-01938-6.
Understanding tissue-resident macrophages unlocks the potential for novel combinatorial strategies in breast cancer.
Biswas M
Front Immunol. 2024; 15:1375528.
PMID: 39104525
PMC: 11298421.
DOI: 10.3389/fimmu.2024.1375528.
The glutathione S-transferase Gstt1 drives survival and dissemination in metastases.
Ferrer C, Cho H, Boon R, Bernasocchi T, Wong L, Cetinbas M
Nat Cell Biol. 2024; 26(6):975-990.
PMID: 38862786
DOI: 10.1038/s41556-024-01426-7.
The role of IL-1B in breast cancer bone metastasis.
Zhou J, Ottewell P
J Bone Oncol. 2024; 46:100608.
PMID: 38800348
PMC: 11127524.
DOI: 10.1016/j.jbo.2024.100608.
Platelets favor the outgrowth of established metastases.
Garcia-Leon M, Liboni C, Mittelheisser V, Bochler L, Follain G, Mouriaux C
Nat Commun. 2024; 15(1):3297.
PMID: 38740748
PMC: 11091169.
DOI: 10.1038/s41467-024-47516-w.
Respiratory viral infection promotes the awakening and outgrowth of dormant metastatic breast cancer cells in lungs.
Chia S, Johnson B, Hu J, Vermeulen R, Chadeau-Hyam M, Guntoro F
Res Sq. 2024; .
PMID: 38645169
PMC: 11030513.
DOI: 10.21203/rs.3.rs-4210090/v1.
Diagnostic value of circulating tumor cells in patients with thyroid cancer: a retrospective study of 1478 patients.
Zeng Q, Zhong H, Rao H, Wang Y
Discov Oncol. 2024; 15(1):114.
PMID: 38607590
PMC: 11014821.
DOI: 10.1007/s12672-024-00976-4.
Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer.
Bagheri M, Mohamed G, Mohamed Saleem M, Ognjenovic N, Lu H, Kolling F
Cell Rep Med. 2024; 5(4):101504.
PMID: 38593809
PMC: 11031425.
DOI: 10.1016/j.xcrm.2024.101504.